4 results match your criteria: "Jiaxing Blood Center[Affiliation]"
Zhonghua Yi Xue Yi Chuan Xue Za Zhi
March 2023
Laboratory Department, Jiaxing Blood Center, Jiaxing, Zhejiang 314033, China.
Objective: To analyze the serological characteristics and molecular mechanism for an individual with p phenotype.
Methods: An individual with p phenotype upon blood group identification at Jiaxing Blood Center in May 2021 was analyzed. ABO, RhD and P1PK blood groups and irregular antibodies in her serum were identified using conventional serological methods.
Molecules
November 2022
School of Life Science, Shandong University, Qingdao 266237, China.
The present study aims to analyze the structural characterization and antioxidant activity of a novel exopolysaccharide from (EPS2-1). For this purpose, EPS2-1 was purified through DEAE-52, Sephadex G-100, and Sephadex G-75 chromatography. The structural characterization of EPS2-1 was analyzed using high-performance gel permeation chromatography (HPGPC), Fourier transform infrared spectroscopy (FT-IR), methylation analysis, nuclear magnetic resonance (NMR) spectra, transmission electron microscope (TEM), and atomic force microscope (AFM).
View Article and Find Full Text PDFDis Markers
September 2018
Center of Laboratory Medicine, Zhejiang Provincial People's Hospital and People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang Province, China.
It would be important to predict type 2 diabetes mellitus (T2DM) and diabetic nephropathy (DN). This study was aimed at evaluating the predicting significance of hemostatic parameters for T2DM and DN. Plasma coagulation and hematologic parameters before treatment were measured in 297 T2DM patients.
View Article and Find Full Text PDFVirus Res
October 2014
National Institutes for Food and Drug Control, Beijing, China. Electronic address:
Human T-lymphotropic virus (HTLV) infection is a high risk factor for lymphoproliferative, inflammatory, and infectious disorders. The epidemiology of HTLV-I, II in industrialized countries has been intensively investigated, and mandatory screening of blood supplies for HTLV-I/II was implemented in mid-1980s in most developed and several developing countries, yet no expanding investigation has been executed in China so far and also been considered as a non-endemic region. However, Gessain et al.
View Article and Find Full Text PDF